Text size A A

About AGTC

Visionary science for life-changing cures

AGTC is a biotechnology company seeking to transform the lives of patients with rare and debilitating eye diseases through its proprietary gene therapy platform.

Our team is made of industry-leading experts and innovative thinkers working together on discoveries that we hope will transform the lives of people with rare inherited eye disorders. In particular, we are studying how to use our gene therapy platform in disorders that are caused by single-gene mutations and that also have a significant effect on a person’s sight.

AGTC is headquartered in Alachua, Fla., with offices in Cambridge, Mass.

For more information about AGTC and updates on our clinical trials, please visit our corporate site. 

Be a part of finding a treatment for achromatopsia Join Us